GOOGLE MAPS AND RSS INTEGRATION IN ANDROID

This paper describes the process of integrating Google Maps API V2 as well as RSS feeds into an Android project. Authors have made an application. The basic purpose of this application is to use it as an introductory application to get our hands dirty on native Java coding and embark upon our research domains; un-burdened and with a smoother paradigm of thoughts. It is also useful for any Android developer to get a command on the basic algorithms which deal with Google Maps and other very important client - based and efficiency - enabling offline applications. Basically, it’s the textual modelling of our first Android based basic – level application

Unlocking Electronic Lock using Biometrics

Being an engineering student, it often happens students have to carry a lot of things to college: mini drafter, project models, football, laptop et cetera. There is always a chance of breaking, losing these things while travelling to and from college. Students forget their assignments and submissions on their due dates. So out of curiosity we began wondering about possibility of having lockers in our college. How better it would be for students! All the unwanted stuff for the lecture can be stuffed inside the lockers till the time required. So this project aims at implementing a way to control electronic lock in the locker to unlock when the user has his identity identified by using biometrics. Biometrics is a growing research and development field. By using biometrics for user identity verification in our project we are encouraging ourselves to explore the field of biometrics which has tremendous potential in the near-future

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer

BACKGROUND: Addition of nimotuzumab to weekly cisplatin and radiation improves outcomes in head and neck cancer. HPV negative oropharyngeal cancer has unsatisfactory treatment outcomes and is a candidate for escalation of treatment. We wanted to determine whether the addition of nimotuzumab to cisplatin-radiation could improve outcomes in these poor-risk tumors.METHODS: This was a subgroup analysis of a phase 3 randomized study. In this study, locally advanced head and neck cancer patients undergoing definitive chemoradiation were randomly allocated to weekly cisplatin (30 mg/m2 IV)- radiation (66–70 Gy) {CRT arm} or nimotuzumab (200 mg weekly) -weekly cisplatin (30 mg/m2)-radiation (66–70 Gy) {NCRT arm}. The data of HPV negative oropharyngeal cancer was extracted from the database of this study for the analysis. HPV testing was done with p16 immunohistochemistry (IHC) staining and reported according to the CAP criteria. The outcomes assessed were progression-free survival (PFS), disease-free survival (DFS), locoregional control, and overall survival (OS). Interaction test was performed between the study arms and HPV status prior to doing any HPV specific analysis for each of the studied outcomes. Kaplan Meier estimates for 2 year OS with 95% CI was calculated. The hazard ratio was obtained using COX regression analysis.RESULTS: We had 187 HPV negative oropharyngeal cancers, 91 in the CRT arm and 96 in NCRT arm. The interaction test was significant for PFS (p = 0.000), locoregional control (p = 0.007) and overall survival (p = 0.002) but not for DFS (p = 0.072). The 2- year PFS was 31.5% (95%CI 21.5–42) in CRT arm versus 57.2% (95%CI 45.8–67.1) in NCRT arm (HR -0.54; 95%CI 0.36–0.79, p = 0.002). The 2-year LRC was 41.4% (95%CI 29.8–52.6) in the CRT arm versus in 60.4% (95%CI 48.7–70.2) in the NCRT arm (HR -0.61; 95%CI 0.4–0.94, p = 0.024). The addition of nimotuzumab also lead to an improvement in 2-year OS from 39.0% (95%CI 28.4–49.6) to 57.6% (95%CI 46.3–67.4) (HR-0.63, 95%CI 0.43–0.92, p = 0.018).CONCLUSIONS: The addition of nimotuzumab to weekly cisplatin-radiation improves outcomes inclusive of OS in HPV negative oropharyngeal cancers.<br/

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer

BACKGROUND: Addition of nimotuzumab to weekly cisplatin and radiation improves outcomes in head and neck cancer. HPV negative oropharyngeal cancer has unsatisfactory treatment outcomes and is a candidate for escalation of treatment. We wanted to determine whether the addition of nimotuzumab to cisplatin-radiation could improve outcomes in these poor-risk tumors.METHODS: This was a subgroup analysis of a phase 3 randomized study. In this study, locally advanced head and neck cancer patients undergoing definitive chemoradiation were randomly allocated to weekly cisplatin (30 mg/m2 IV)- radiation (66–70 Gy) {CRT arm} or nimotuzumab (200 mg weekly) -weekly cisplatin (30 mg/m2)-radiation (66–70 Gy) {NCRT arm}. The data of HPV negative oropharyngeal cancer was extracted from the database of this study for the analysis. HPV testing was done with p16 immunohistochemistry (IHC) staining and reported according to the CAP criteria. The outcomes assessed were progression-free survival (PFS), disease-free survival (DFS), locoregional control, and overall survival (OS). Interaction test was performed between the study arms and HPV status prior to doing any HPV specific analysis for each of the studied outcomes. Kaplan Meier estimates for 2 year OS with 95% CI was calculated. The hazard ratio was obtained using COX regression analysis.RESULTS: We had 187 HPV negative oropharyngeal cancers, 91 in the CRT arm and 96 in NCRT arm. The interaction test was significant for PFS (p = 0.000), locoregional control (p = 0.007) and overall survival (p = 0.002) but not for DFS (p = 0.072). The 2- year PFS was 31.5% (95%CI 21.5–42) in CRT arm versus 57.2% (95%CI 45.8–67.1) in NCRT arm (HR -0.54; 95%CI 0.36–0.79, p = 0.002). The 2-year LRC was 41.4% (95%CI 29.8–52.6) in the CRT arm versus in 60.4% (95%CI 48.7–70.2) in the NCRT arm (HR -0.61; 95%CI 0.4–0.94, p = 0.024). The addition of nimotuzumab also lead to an improvement in 2-year OS from 39.0% (95%CI 28.4–49.6) to 57.6% (95%CI 46.3–67.4) (HR-0.63, 95%CI 0.43–0.92, p = 0.018).CONCLUSIONS: The addition of nimotuzumab to weekly cisplatin-radiation improves outcomes inclusive of OS in HPV negative oropharyngeal cancers.<br/

A RESEARCH ON ANDROID’S TEXT TO SPEECH ENGINE

This paper basically walks through the development of ‘Text-less safe driving’, an application that auto responds to text messages you receive while you’re driving. The driving and texting epidemic which has engulfed the people right since the inception of telephones is not really a good thing when it comes to safety. This basic application deals with this issue by auto – responding according to the users need. It basically responds automatically (and hands-free) to any text with a message such as “I’m driving right now, I’ll contact you shortly.”  It’s also an implementation of how Android provides access to some great working features of the phone, including SMS text processing, database management, text-to-speech, and the location sensor

NANOFLUIDS WITH RECENT APPLICATION & FUTURE TRENDS

This paper provides an overview of enhanced properties of nanofluids which are used in plethora of engineering applications ranging from use in automotive industry to medical arena to use in power plant cooling systems. In addition , it also highlights future work and possibilities. The novel concept of nanofluids in the spring of 1993, talented and studious thermal scientists and engineers in the rapidly growing nanofluids community have made scientific breakthrough not only in discovering unexpected thermal properties of nanofluids , but also in proposing new mechanisms behind enhanced thermal properties of nanofluids. As a result , this research topic of nanofluids has been receiving increasing attention worldwide

Solar power in India: past, present and 2022

by Prathamesh Badve, Navjyot Panpalia, Parth Patel, Priyang Priyadarshi, Saksham Singal, Puneet Swami, Akhil VVS and Dinusha Wickramaarachch

Skull base surgery for malignant tumors: The 2nd international collaborative study (1995-2015)

The current study presents the effort of a global collaborative group to review the management and outcomes of malignant tumors of the skull base worldwide. A total of 28 institutions contributed data on 3061 patients. Analysis evaluated clinical variables, survival outcomes, and multivariable factors associated with outcomes. The median age was 56 years (IQR 44-67). The open surgical approach was used in 55% (n = 1680) of cases, endoscopic resection was performed in 36% (n = 1087), and the combined approach in 9.6% (n = 294). With a median follow-up of 7.1 years, the 5-year OS DSS and RFS were 65%, 71.7% and 53%, respectively. On multivariable analysis, older age, comorbidities, histology, dural/intracranial involvement, positive margins, advanced stage, and primary site were independent prognostic factors for OS, DSS, and RFS. Adjuvant RT was a protective prognostic factor. The progress across various disciplines may have contributed to improved OS and DSS in this study compared to previous reports